^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    AR negative

    i
    Entrez ID:
    367
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    Apply
    TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer (NCT03193853)
    Phase 2
    Joyce O'Shaughnessy
    Completed
    Last update posted :
    08/07/2023
    Initiation :
    07/18/2017
    Primary completion :
    03/17/2020
    Completion :
    12/01/2022
    AR
    |
    AR negative
    |
    cisplatin • albumin-bound paclitaxel • sapanisertib (CB-228) • serabelisib (MLN1117)